Loading...
Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
Seronegative myasthenia gravis is a rare, but potential adverse effect of immune checkpoint inhibition. There have been few but increasing number of cases reported in recent years, and early recognition is important for prompt diagnosis and management. Here, we describe the case of a 65-year-old mal...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216640/ https://ncbi.nlm.nih.gov/pubmed/34178496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15174 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|